PPARγ-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells
Frank Pistrosch, P GROSS, Uta Oelschlaegel(University Hospital Carl Gustav Carus), Jens Passauer, Kay Herbrig, Stefan Richter(University of Illinois Urbana-Champaign), Sabine Fischer
Cited by 156
Related Papers
Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial
|Leukemia|2011|398
Cytarabine Dose of 36 g/m<sup>2</sup> Compared With 12 g/m<sup>2</sup> Within First Consolidation in Acute Myeloid Leukemia: Results of Patients Enrolled Onto the Prospective Randomized AML96 Study
|Journal of Clinical Oncology|2011|102
Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group
|Haematologica|2016|100
Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis
|American Journal of Kidney Diseases|2004|98